Hemolytic uremic syndrome following Campath-1H induction

被引：7

作者：

Bonatti, Hugo

Brandacher, Gerald

Boesmueller, Claudia

Cont, Micol

Hengster, Paul

Rosenkranz, Alexander R.

Krugmann, Jens

Margreiter, Raimund

机构：

[1] Univ Innsbruck, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria

[2] Univ Innsbruck, Div Nephrol, Dept Internal Med, A-6020 Innsbruck, Austria

[3] Med Univ Innsbruck, Inst Pathol, Innsbruck, Austria

来源：

TRANSPLANT INTERNATIONAL | 2007年 / 20卷 / 04期

关键词：

renal transplantation; Campath-1H; haemolytic uremic syndrome; Rapamycin;

D O I：

10.1111/j.1432-2277.2006.00445.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.

引用

收藏

页码：386 / 389

页数：4

相关论文

共 22 条

[1] Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus [J].

Abraham, KA ;

Little, MA ;

Dorman, AM ;

Walshe, JJ .

TRANSPLANT INTERNATIONAL, 2000, 13 (06) :443-447

[2]

Blackall Douglas P, 2004, Am J Clin Pathol, V121 Suppl, pS81

[3] Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients [J].

Calne, R ;

Friend, P ;

Moffatt, S ;

Bradley, A ;

Hale, G ;

Firth, J ;

Bradley, J ;

Smith, K ;

Waldmann, H .

LANCET, 1998, 351 (9117) :1701-1702

[4] Attempted treatment of factor H deficiency by liver transplantation [J].

Cheong, HI ;

Lee, BS ;

Kang, HG ;

Hahn, H ;

Suh, KS ;

Ha, IS ;

Choi, Y .

PEDIATRIC NEPHROLOGY, 2004, 19 (04) :454-458

[5] The use of campath-1H as induction therapy in renal transplantation: Preliminary results [J].

Ciancio, G ;

Burke, GW ;

Gaynor, JJ ;

Mattiazzi, A ;

Roohipour, R ;

Carreno, MR ;

Roth, D ;

Ruiz, P ;

Kupin, W ;

Rosen, A ;

Esquenazi, V ;

Tzakis, AG ;

Miller, J .

TRANSPLANTATION, 2004, 78 (03) :426-433

[6] De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: Role of sirolimus [J].

Franco, A ;

Hernandez, D ;

Capdevilla, L ;

Errasti, P ;

Gonzalez, M ;

Ruiz, JC ;

Sanchez, J .

TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) :1764-1766

[7]

Franz M, 1998, TRANSPLANTATION, V66, P1258

[8]

Gatti S, 2003, J NEPHROL, V16, P586

[9] Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports [J].

Humar, A ;

Jessurun, J ;

Sharp, HL ;

Gruessner, RWG .

TRANSPLANT INTERNATIONAL, 1999, 12 (05) :387-390

[10]

Isaacs JD, 1996, BRIT J RHEUMATOL, V35, P231